# NON-GMP SYNTHESIS OF COMPOUNDS FOR DRUG DEVELOPMENT

> **NIH NIH N02** · ALCHEM LABORATORIES CORPORATION · 2020 · $627,585

## Abstract

The mission will be “Non-GMP” chemical synthesis of compounds of good purity as needed for the cancer program,
such as synthetic compounds mainly prompted by the NCI Experimental Therapeutics (NExT) and Drug Acquisition
Initiative (DAI) programs and also compounds arising from the recommendation of the Biological Evaluation
Committee (BEC). The contract may be utilized for the purpose of synthesis of active single compound leads and their
analogs using parallel synthesis methodology, as sometimes required by programmatic needs.

## Key facts

- **NIH application ID:** 10246234
- **Project number:** 261201600066C-P00006-9999-1
- **Recipient organization:** ALCHEM LABORATORIES CORPORATION
- **Principal Investigator:** VLADIMIR RUDCHENKO
- **Activity code:** N02 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $627,585
- **Award type:** —
- **Project period:** 2016-09-20 → 2021-09-19

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10246234

## Citation

> US National Institutes of Health, RePORTER application 10246234, NON-GMP SYNTHESIS OF COMPOUNDS FOR DRUG DEVELOPMENT (261201600066C-P00006-9999-1). Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/grant/nih/10246234. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*